David Almeida picks his landmark paper of 2018, whose main author also gives us an inside perspective.
David Almeida | | Quick Read
The tide is turning for patients with vision-degrading vitreopathy.
Landmark paper: J Sebag et al., “Long-Term Safety and Efficacy of Limited Vitrectomy for Vision Degrading Vitreopathy Resulting from Vitreous Floaters”, Ophthalmology Retina, 9, 881–887 (2018). DOI: e201803011
This study, published in September 2018, looked at outcomes of patients undergoing vitrectomy for vitreous opacities, also known as vitreous floaters (1). Vitreous opacities contribute to the disease entity of vision-degrading vitreopathy, which can lower visual acuity (VA) and degrade contrast sensitivity function (CSF). Vitrectomy for floaters has remained controversial, and much debate has occurred about the appropriateness of vitreoretinal surgery for patients with good VA but bothersome floaters; however, with the widespread adoption of micro incisional vitrectomy surgery (MIVS), efficient and safe surgical approaches are available that should be considered. Prior to this study, long-term results in a large series with objective quantitative outcome measures were lacking.
Read the full article now
Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.